Inactief instrument
Koers Tetraphase Pharmaceuticals, Inc.
Aandelen
US88165N2045
Farmaceutische producten
| Bedrijfsleider | Titel | Leeftijd | Van |
|---|---|---|---|
Pavel Raifeld
PSD | President | 42 | - |
Katherine Dorris
SEC | Bedrijfssecretaris | - | - |
Stephen Basso
TRE | Treasurer | 60 | - |
| Bestuurder | Titel | Leeftijd | Van |
|---|---|---|---|
Pavel Raifeld
BRD | Directeur/Bestuurslid | 42 | - |
| Datum | Insider | Type | Hoofdpost | Volume | % marktkap. | |
|---|---|---|---|---|---|---|
| 28/07/20 | Tender | Directeur juridische afdeling | 15.022 | 0,2068% | ||
| 28/07/20 | Koop | Onderneming | 3.737.360 | 51,4559% | ||
| 28/07/20 | Tender | Director | 15.703 | 0,2162% |
Toevoegen aan een lijst 0 geselecteerde | Verschil (%) | Varia. 5d. | Varia. 1j. | Varia. 3j. | Kap.($) | |
|---|---|---|---|---|---|---|
 | -.--% | -10,93% | - | - | 16,07 mln. | |
| -2,31% | -6,60% | +45,45% | +149,03% | 1.024 mld. | |
| -0,66% | -4,28% | +48,83% | +49,18% | 618 mld. | |
| -1,88% | -3,82% | +25,31% | +65,78% | 443 mld. | |
| +0,68% | -1,14% | +39,61% | +33,36% | 349 mld. | |
| -1,66% | -3,13% | +31,63% | +39,79% | 297 mld. | |
| -8,96% | -10,77% | +3,27% | +5,50% | 264 mld. | |
| -1,37% | -7,41% | -3,42% | -43,67% | 209 mld. | |
| -1,55% | +0,58% | +25,34% | +64,04% | 208 mld. | |
| +0,41% | -0,03% | +13,94% | +72,75% | 162 mld. | |
| Gemiddelde | -1,83% | -1,35% | +25,55% | +48,42% | 397,08 mld. | |
| Gewogen gemiddelde per kap. | -2,00% | -2,17% | +33,26% | +70,82% |
Werknemers
-
Sector
Farmaceutische producten
